Subsequently, we used the genetic variants PNPLA3 and TM6SF2, both strongly associated with NAFLD and high liver fat content, to test whether NAFLD was causally associated with increased risk of psoriasis. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.